Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

Evaluation of Effectiveness and Safety of Synergy™ XD Stent and Synergy Megatron™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study

The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.

This study is a non-randomized, prospective, open-label registry to compare the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stents versus other drug-eluting stents (DES) in patients with coronary artery disease.

Inclusion Criteria:

• Patients ≥ 19 years old
• Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s).
• The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion Criteria:

• Patients with a mixture of other drug-eluting stents (DESs)
• Terminal illness with life-expectancy ≤1 year.
• Patients with cardiogenic shock